A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers
Bendell, Johanna C., Zakari, Ahmed, Lang, Evan, Waterhouse, David, Flora, Douglas, Alguire, Kathryn, McCleod, Michael, Peacock, Nancy, Ruehlman, Peter, Lane, Cassie M., Earwood, Chris, Shih, KentLanguage:
english
Journal:
Cancer Investigation
DOI:
10.3109/07357907.2016.1174257
Date:
April, 2016
File:
PDF, 721 KB
english, 2016